New intensive program aims to prevent suicide in At-Risk adults
NCT ID NCT07655986
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a high-resolution, multidisciplinary suicide prevention program for adults at moderate-to-high risk. Participants receive intensive follow-up from a team of nurses, psychiatrists, psychologists, and social workers over three months, plus weekly group therapy. The goal is to see if this program reduces suicide attempts and hospitalizations compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Suicide Prevention Program (PPS) - a behavioral intervention with intensive follow-up and group therapy
- What this could lead to
- If successful, this could provide an effective, community-based model for preventing suicide attempts and reducing hospitalizations.
- What could go wrong
- This is a relatively small, non-randomized study, so results may not apply broadly. The program is intensive and may not be feasible in all settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 198 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients ≥ 18 years of age. * No prior active follow-up by the mental health team. * Prior stabilization by the emergency psychiatry team. * Columbia Severity Rating Scale (C-SSRS) score corresponding to moderate-to-high risk. * Absence of criteria for urgent hospital admission. * Signed informed consent. Exclusión Criteria: * Self-harm without suicidal intent. * Mild suicide risk (mild C-SSRS). * Extremely high suicide risk requiring urgent hospital admission. * Patient under active follow-up at another mental health unit.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prevention of suicidal behavior are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Salamanca, 37185, Spain